Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression

Detalhes bibliográficos
Autor(a) principal: Conceição, isabel
Data de Publicação: 2019
Outros Autores: Coelho, Teresa, Rapezzi, Claudio, Parman, Yeşim, Obici, Laura, Galán, Lucía, Rousseau, Antoine
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/46443
Resumo: © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon inany way.
id RCAP_624724cd0a20458506c84d9d7b05dab9
oai_identifier_str oai:repositorio.ul.pt:10451/46443
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progressionATTRAmyloidosisFollow-upHereditaryMonitoringProgressionTransthyretin© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon inany way.Timely diagnosis of hereditary variant transthyretin (ATTRv) amyloidosis is critical for appropriate treatment and optimal outcomes. Significant differences are seen between patients receiving treatment and those who are not, though disease progression may continue despite treatment in some patients. Healthcare professionals caring for patients with ATTRv amyloidosis therefore need reliable ongoing assessments to understand the continuing course of disease and make appropriate treatment choices on an individual basis. Various signs and symptoms experienced by patients may be evaluated as indicators of disease progression, though there is currently no validated score that can be used for such ongoing assessment. Recognizing this situation, a group of clinicians highly experienced in ATTR amyloidosis developed an approach to understand and define disease progression in diagnosed and treated patients with ATTRv amyloidosis. The suggested approach is based on the recognition of distinct phenotypes which may usefully inform the particular tools, tests and investigations that are most likely to be appropriate for individual patients. It is aimed at implementing appropriate and ongoing assessment of patients being treated for ATTRv amyloidosis, such that the effectiveness of management can be usefully assessed throughout the course of disease and management can be tailored according to the patient’s requirements.Taylor & Francis GroupRepositório da Universidade de LisboaConceição, isabelCoelho, TeresaRapezzi, ClaudioParman, YeşimObici, LauraGalán, LucíaRousseau, Antoine2021-02-19T14:32:38Z20192019-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/46443engAmyloid. 2019 Sep;26(3):103-1111350-612910.1080/13506129.2019.1627312info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:48:44Zoai:repositorio.ul.pt:10451/46443Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:58:37.235017Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
title Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
spellingShingle Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
Conceição, isabel
ATTR
Amyloidosis
Follow-up
Hereditary
Monitoring
Progression
Transthyretin
title_short Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
title_full Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
title_fullStr Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
title_full_unstemmed Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
title_sort Assessment of patients with hereditary transthyretin amyloidosis : understanding the impact of management and disease progression
author Conceição, isabel
author_facet Conceição, isabel
Coelho, Teresa
Rapezzi, Claudio
Parman, Yeşim
Obici, Laura
Galán, Lucía
Rousseau, Antoine
author_role author
author2 Coelho, Teresa
Rapezzi, Claudio
Parman, Yeşim
Obici, Laura
Galán, Lucía
Rousseau, Antoine
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Conceição, isabel
Coelho, Teresa
Rapezzi, Claudio
Parman, Yeşim
Obici, Laura
Galán, Lucía
Rousseau, Antoine
dc.subject.por.fl_str_mv ATTR
Amyloidosis
Follow-up
Hereditary
Monitoring
Progression
Transthyretin
topic ATTR
Amyloidosis
Follow-up
Hereditary
Monitoring
Progression
Transthyretin
description © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon inany way.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019-01-01T00:00:00Z
2021-02-19T14:32:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/46443
url http://hdl.handle.net/10451/46443
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Amyloid. 2019 Sep;26(3):103-111
1350-6129
10.1080/13506129.2019.1627312
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Taylor & Francis Group
publisher.none.fl_str_mv Taylor & Francis Group
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134532454055936

Registros relacionados